Metabolic engineering

01Overview and value chain

Markers: [EC: 20.14 | OECD: industrial-biotech | Regulator: EPA (US), NMPA (China), EFSA (EU)]

Metabolic engineering is the foundational technology of industrial biotechnology, enabling the rational design and optimization of cellular pathways to transform microorganisms into highly efficient bio-factories. By precisely editing the genomes of host organisms such as E. coli, Saccharomyces cerevisiae, or Corynebacterium glutamicum, scientists can divert carbon fluxes toward the synthesis of valuable target molecules, achieving yields that exceed 80% of the theoretical maximum. The process integrates advanced bioinformatics, CRISPR-Cas9 genome editing, and machine learning to map out and construct entirely non-natural metabolic routes. Operating in bioreactors ranging from 1,000 to over 500,000 liters, metabolically engineered strains produce amino acids, bio-polymers, organic acids, and pharmaceutical precursors, fundamentally shifting the chemical industry away from petrochemical dependency and toward sustainable, bio-based feedstocks.

The key directions of metabolic engineering are:

1. Strain Engineering (Cell Programming): Utilizing high-throughput robotics and machine learning to rapidly prototype and test millions of genetic variants.
2. C1 Gas Fermentation: Engineering acetogenic bacteria to metabolize industrial off-gases (CO, CO2) directly into ethanol and platform chemicals.
3. Precision Fermentation: Optimizing yeast and fungal strains for the high-yield production of complex nutritional molecules, flavors, and vitamins.
4. Bio-based Monomers: Rerouting metabolic fluxes to synthesize long-chain dicarboxylic acids and diamines for high-performance bio-polyamides.

Sectoral value chain

[Strain Design] ──> [Pathway Optimization] ──> [Pilot Fermentation] ──> [Scale-up]
                                  │
                          (Platform Chemicals)
                                  │
                                  ▼
[Consumer Goods] <─── [Downstream Processing] <─────┘

Value chain levels

Cross-cutting technologies of the sector:

• CRISPR-Cas Multiplexing: simultaneous editing of multiple target genes to rewire complex metabolic networks in a single generation.
• High-Throughput Screening (HTS): automated microfluidic systems coupled with mass spectrometry to evaluate the productivity of thousands of strains daily.
• Flux Balance Analysis (FBA): mathematical modeling of intracellular metabolic networks to predict optimal gene knockout and overexpression strategies.

02US

The US leads the global market in cell programming platforms and the commercialization of novel gas fermentation technologies, backed by massive venture capital.

cell programming, gas fermentation, synthetic biology hubs

• Ginkgo Bioworks Foundry: operating a massive, automated platform (“The Foundry”) that provides custom strain engineering as a service to global chemical and pharma giants.
• LanzaTech CarbonSmart: pioneering commercial-scale gas fermentation by deploying engineered acetogens at steel mills to capture and convert emissions into chemical building blocks.
• Department of Energy (DOE) Grants: heavy federal funding driving the development of robust microbial chassis capable of utilizing diverse, low-cost lignocellulosic feedstocks.

03CN

China aggressively scales metabolic engineering to dominate the global supply of amino acids, organic acids, and bio-based polyamides, aiming for industrial self-sufficiency.

bio-manufacturing scale, amino acids, synthetic biology parks

• Cathay Biotech Polyamides: leading the global commercialization of bio-based long-chain diacids and bio-polyamides through proprietary engineered strains.
• Huaheng Bio Dominance: utilizing highly optimized anaerobic fermentation processes to become the world’s largest producer of L-alanine and other high-value amino acids.
• State-Sponsored SynBio Hubs: massive government investments in synthetic biology innovation centers in Shenzhen and Tianjin to accelerate the translation from lab to mega-factory.

04EU

The EU focuses on the precision fermentation of high-value nutritional ingredients and sustainable surfactants, driven by strict green chemistry mandates.

precision fermentation, bio-surfactants, circular bioeconomy

• Evonik Biosurfactants: deploying advanced metabolic engineering to produce 100% bio-based and biodegradable rhamnolipids at commercial scale in Slovakia.
• DSM-Firmenich Nutrition: utilizing rationally designed yeast and fungal strains for the direct, sustainable synthesis of vitamins, carotenoids, and complex flavor profiles.
• Circular Bio-based Europe (CBE JU): public-private partnerships funding the development of cell factories that convert agricultural residues into drop-in chemicals.

05Leading companies and research institutes

06Tech stack and innovations

Metabolic engineering relies on the seamless integration of computational biology, advanced molecular tools, and highly monitored bioprocessing.

1. Computational Strain Design:
   • Algorithms predict the theoretical maximum yields of target molecules using genome-scale metabolic models (GEMs) comprising over 3,000 biochemical reactions.
   • Machine learning models analyze transcriptomic and metabolomic data to identify regulatory bottlenecks and non-obvious gene targets for disruption.
2. Genetic Assembly and Editing:
   • Automated DNA synthesis and modular assembly techniques (like Golden Gate) construct vast libraries of pathway variants containing different promoters and terminators.
   • CRISPR-associated transposases allow for the stable, multiplexed integration of large biosynthetic gene clusters directly into the host chromosome.
3. Bioreactor Process Control:
   • Multi-omics sensors continuously monitor pH, dissolved oxygen, and specific metabolite concentrations in real-time.
   • Dynamic control strategies, such as optogenetics, use light to independently switch metabolic pathways from a “growth phase” to a “production phase” maximizing yields.

07Value chains and production pipelines

Industrial pipeline of microbial cell factories (ISO 23418)

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. In silico design       │ ───> │ 2. Genetic construction   │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Pilot optimization     │ <─── │ 3. High-throughput screen │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Industrial scale-up    │ ───> │ 6. Recovery & formulation │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: In silico design

Running flux balance analysis on the selected microbial chassis to identify the optimal gene knockouts and insertions required to maximize the carbon flow to the target molecule.

Stage 2: Genetic construction

Synthesizing the designed DNA cassettes and seamlessly integrating them into the host genome using CRISPR-Cas9 to create a library of 10,000 distinct prototype strains.

Stage 3: High-throughput screen

Cultivating the engineered strains in automated micro-bioreactors (1-10 mL) while mass spectrometry rapidly quantifies the target molecule titer to identify the top 5 performers.

Stage 4: Pilot optimization

Transferring the winning strains into 1,000-liter pilot fermenters to fine-tune the feeding strategy, aeration rates, and dynamic pathway regulation under realistic industrial conditions.

Stage 5: Industrial scale-up

Inoculating massive 500,000-liter commercial bioreactors with the optimized strain and continuously feeding it low-cost sugars or captured off-gases to achieve maximum volumetric productivity.

Stage 6: Recovery & formulation

Harvesting the fermentation broth, centrifuging the cell mass, and purifying the target chemical through crystallization or chromatography before packaging for B2B distribution.